logo

For the Inventor, By the Inventor

Tuxedo Park, NY, United States of America

Joseph J Hlavka

This inventor holds 53 USPTO granted patents, primarily in Tetracycline Derivatives (CPC class 5483). Top assignees: American Cyanamid Company, Innapharma, Inc., Collagenex Pharmaceuticals, Incorporated. Active years: 1976-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph J Hlavka. Retrieved from https://idiyas.com/inventor/joseph-j-hlavka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53

% Patents Active = 90.6

Average Co-Inventor Count = 2.8

ph-index = 16

Forward Citations = 864(Granted Patents)

Forward Citations (Not Self Cited) = 807(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Tuxedo, NY (US) (1976 - 2001)
  • Tuxedo Park, NY (US) (1977 - 2008)
  • Suffern, NY (US) (2003 - 2008)

Company Filing History:

goldMedal39 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal7 out of 8 
 
Innapharma, Inc.
 patents
bronzeMedal2 out of 10 
 
Collagenex Pharmaceuticals, Incorporated
 patents
4. 2 out of 113 
 
Wyeth Holdings Corporation
 patents
5. 1 out of 27 
 
Galderma Laboratories Inc.
 patents
6. 1 out of 1 
 
Tetragenex Pharmaceuticals, Inc.
 patent
7. 1 out of 834,453 
Other
 patents

Years Active: 1976-2008

Loading Chart...
Areas of Expertise:
Tetracycline Derivatives
Platinum Complexes
Peptidomimetics
Bacterial Infection
HIV Treatment
Oncogenic Inhibition
Tripeptides
Tetra Peptides
Penta Peptides
Synthesis Methods
Novel Therapeutics
53 patents (USPTO):Explore Patents
1. 7456158 - 4-dedimethylaminotetracycline derivatives (2008-11-25),
2. RE40183 - 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines (2008-03-24),
3. RE40086 - Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines (2008-02-18),
4. 7214669 - Tetracycline derivatives and methods of use thereof (2007-05-08),
5. 6894036 - 4-dedimethylaminotetracycline derivatives (2005-05-17),
6. 6767897 - Therapeutic uses of tri-, tetra-, penta-, and polypeptides (2004-07-27),
7. 6638922 - 4-dedimethylaminotetracycline derivatives (2003-10-28),
8. 6506740 - 4-dedimethylaminotetracycline derivatives (2003-01-14),
9. 6281365 - (Gem-heterocyclodimethanamine-n,n′)platinum complexes (2001-08-28),
10. 6093797 - Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an (2000-07-25),
11. 5990172 - Peptidomimetics for the treatment of HIV infection (1999-11-23),
12. 5910478 - Peptidomimetics inhibiting the oncogenic action of p21 ras (1999-06-08),
13. 5886175 - 7-(substituted)-8-(substituted)-9-(substitued (1999-03-23),
14. 5840683 - Peptides inhibiting the oncogenic action of p21 ras (1998-11-24),
15. 5767083 - Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an (1998-06-16),

Title: Joseph J Hlavka: Pioneer in Tetracycline Derivatives

Introduction

Joseph J Hlavka, a prolific inventor based in Tuxedo Park, NY, has significantly contributed to the field of medicinal chemistry with an impressive portfolio of 53 patents. His work primarily focuses on novel tetracycline compounds that hold potential therapeutic applications.

Latest Patents

Hlavka's latest innovations include the development of 4-dedimethylaminotetracycline derivatives. This invention introduces chemically modified tetracycline compounds that are amenable to substitution with aryl, alkenyl, or alkynyl groups. These derivatives can be utilized in treating various conditions by administering effective amounts of these novel compounds. Additionally, Hlavka has worked on 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracycline compounds, which have demonstrated broad-spectrum antibiotic properties.

Career Highlights

Throughout his career, Hlavka has held notable positions in esteemed companies such as American Cyanamid Company and Innapharma, Inc. His expertise and innovative spirit have allowed him to pave the way for advancements in antibiotic development, significantly impacting public health.

Collaborations

Hlavka's journey has been characterized by collaboration with talented individuals, including Panayota Bitha and Yang-I Lin. Their joint efforts have fostered an environment of creativity and scientific inquiry, leading to important advancements in the pharmaceutical field.

Conclusion

Joseph J Hlavka's contributions as an inventor and innovator in tetracycline derivatives exemplify the crucial role of research and development within the medicinal chemistry landscape. His commitment to improving health outcomes through novel pharmaceutical compounds is commendable and continues to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…